These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


259 related items for PubMed ID: 9696650

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.
    Yeomans ND, Tulassay Z, Juhász L, Rácz I, Howard JM, van Rensburg CJ, Swannell AJ, Hawkey CJ.
    N Engl J Med; 1998 Mar 12; 338(11):719-26. PubMed ID: 9494148
    [Abstract] [Full Text] [Related]

  • 5. [Prevention of ulcer lesions under non-steroid antirheumatic agents. For each patient the appropriate stomach protection].
    MMW Fortschr Med; 2004 May 27; 146(22):48. PubMed ID: 15373113
    [No Abstract] [Full Text] [Related]

  • 6. The impact of nonsteroidal anti-inflammatory drug-induced gastropathy.
    Scheiman JM.
    Am J Manag Care; 2001 Feb 27; 7(1 Suppl):S10-4. PubMed ID: 11225347
    [Abstract] [Full Text] [Related]

  • 7. Misoprostol vs omeprazole for ulcers associated with NSAIDs.
    Bell AD.
    Can Fam Physician; 1998 Nov 27; 44():2371-2. PubMed ID: 9839045
    [No Abstract] [Full Text] [Related]

  • 8. [NSAID ulcer (H. pylori, treatment, prevention)].
    Ohta S, Arai S, Imai Y, Banba H.
    Nihon Rinsho; 2004 Mar 27; 62(3):505-11. PubMed ID: 15038095
    [Abstract] [Full Text] [Related]

  • 9. Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.
    Weilert F, Smith AC, Stokes PL.
    N Engl J Med; 1998 Jul 30; 339(5):349; author reply 350-1. PubMed ID: 9696649
    [No Abstract] [Full Text] [Related]

  • 10. [The outline of medical treatment of peptic ulcer].
    Nakamura T.
    Nihon Rinsho; 2002 Feb 30; 60 Suppl 2():365-70. PubMed ID: 11979808
    [No Abstract] [Full Text] [Related]

  • 11. Omeprazole or misoprostol. Which works best for NSAID-induced ulcers?
    Gautam M, Por CP, Evans MF.
    Can Fam Physician; 1998 Aug 30; 44():1629-31. PubMed ID: 9721418
    [No Abstract] [Full Text] [Related]

  • 12. Prevention of NSAID-induced GI mucosal injury.
    Gerritz S, Newton WP.
    J Fam Pract; 1997 Feb 30; 44(2):130-1. PubMed ID: 9040509
    [No Abstract] [Full Text] [Related]

  • 13. Omeprazole to prevent recurrent bleeding after endoscopic treatment of ulcers.
    Libby ED.
    N Engl J Med; 2000 Aug 03; 343(5):358-9. PubMed ID: 10922427
    [No Abstract] [Full Text] [Related]

  • 14. Reducing clinically significant gastrointestinal toxicity associated with nonsteroidal antiinflammatory drugs.
    Jacobsen RB, Phillips BB.
    Ann Pharmacother; 2004 Sep 03; 38(9):1469-81. PubMed ID: 15213313
    [Abstract] [Full Text] [Related]

  • 15. The management of upper gastrointestinal problems in patients taking NSAIDs.
    Prichard P.
    Aust Fam Physician; 1991 Dec 03; 20(12):1739-41. PubMed ID: 1687198
    [Abstract] [Full Text] [Related]

  • 16. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
    Graham DY.
    Am J Med; 2001 Jan 08; 110(1A):58S-61S. PubMed ID: 11166000
    [Abstract] [Full Text] [Related]

  • 17. Healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions, and relief of dyspeptic symptoms: a commentary on the new data.
    Talley NJ.
    Am J Med; 1998 Mar 30; 104(3A):62S-66S; discussion 79S-80S. PubMed ID: 9572323
    [No Abstract] [Full Text] [Related]

  • 18. Drugs for treatment of peptic ulcers.
    Med Lett Drugs Ther; 1991 Nov 29; 33(858):111-4. PubMed ID: 1682791
    [No Abstract] [Full Text] [Related]

  • 19. [Gastric lesion caused by NSAID and inflammation due to Helicobacter pylori. Is there potentiation or attenuation?].
    Lanas Arbeloa A, Serrano Aulló MT.
    Gastroenterol Hepatol; 1998 Jan 29; 21 Suppl 1():20-4. PubMed ID: 9549198
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.